Cargando…
The new frame for Mucopolysaccharidoses
Mucopolysaccharidoses (MPS) are genetic, progressive, lysosomal storage disorders affecting virtually all organs and systems. The first MPS were clinically identified about 100 years ago. Nowadays, the enzyme defects and related genes are known for all 11 different enzyme defects. Treatments are ava...
Autores principales: | Parini, Rossella, Biondi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238248/ https://www.ncbi.nlm.nih.gov/pubmed/30442168 http://dx.doi.org/10.1186/s13052-018-0549-y |
Ejemplares similares
-
Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
por: Parini, Rossella, et al.
Publicado: (2020) -
Immunodiagnosis of tuberculosis: new questions, new tools conference 2008
por: Gennaro, Maria L, et al.
Publicado: (2010) -
Osteo-Rheumatology: a new discipline?
por: Bianchi, Gerolamo, et al.
Publicado: (2012) -
New perspectives on psychoanalytic clinical processes
por: Yerushalmi, Hanoch
Publicado: (2021) -
New perspectives on the evolution of women's cooperation
por: Fox, Stephanie A., et al.
Publicado: (2023)